News

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...
Welcome to "Medical Mavericks," a series from MedPage Today featuring interviews with healthcare professionals working in unconventional fields of health and medicine.
Inside cells, two important enzymes act like small central regulatory hubs: dipeptidyl peptidase 8 and 9 – DPP8/9 for short. Among other things, they ...
Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ...
Globe Magazine profile of the reclusive investor and philanthropist who’d quietly bought up half of Harvard Square.
An INRS team discovers a new family of enzymes capable of inducing targeted cuts in single-stranded DNA. A few years ago, the ...
Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will ...
A Russian scientist who works at Harvard University’s Medical School has spent the last ... and he and Petrova’s colleagues have sent her books to help pass time. She is being held in a ...
During the fourth quarter, the Harbor Health Care ETF returned –10.89%, underperforming the Russell 3000 Growth Health Care ...
AdvaMed and other healthcare groups have pleaded for the Trump administration to exempt medical devices and critical supplies ...